BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30739914)

  • 1. Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development.
    Dorssers LCJ; Gillis AJM; Stoop H; van Marion R; Nieboer MM; van Riet J; van de Werken HJG; Oosterhuis JW; de Ridder J; Looijenga LHJ
    Br J Cancer; 2019 Feb; 120(4):444-452. PubMed ID: 30739914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
    Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
    BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
    Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
    BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oncofetal and developmental perspective on testicular germ cell cancer.
    Rijlaarsdam MA; Looijenga LH
    Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.
    Miyai K; Ito K; Nakanishi K; Tsuda H
    Hum Pathol; 2019 Feb; 84():71-80. PubMed ID: 30266250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic evolution and chemoresistance in germ-cell tumours.
    Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
    Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
    Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
    Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
    Shekhani MT; Barber JR; Bezerra SM; Heaphy CM; Gonzalez Roibon ND; Taheri D; Reis LO; Guner G; Joshu CE; Netto GJ; Meeker AK
    Hum Pathol; 2016 Aug; 54():106-12. PubMed ID: 27085557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testicular germ cell tumors: Histopathological and molecular features].
    Tourne M; Radulescu C; Allory Y
    Bull Cancer; 2019 Apr; 106(4):328-341. PubMed ID: 30905378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer?
    Bang AK; Busch AS; Almstrup K; Gromoll J; Kliesch S; Rajpert-De Meyts E; Skakkebaek NE; Juul A; Tüttelmann F; Jørgensen N
    Andrology; 2018 Jan; 6(1):176-183. PubMed ID: 29179257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analyses of refractory testicular germ cell tumors.
    Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
    PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
    Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
    Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression.
    Miyai K; Ito K; Nakanishi K; Tsuda H
    Virchows Arch; 2019 Jun; 474(6):711-720. PubMed ID: 30877382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of testis cancer: association of alterations with outcome of clinical stage 1 mixed germ cell nonseminomatous germ cell tumor of the testis.
    Mohamed GH; Gelfond JA; Nicolas MM; Brand TC; Sarvis JA; Leach RJ; Johnson-Pais TL
    Urology; 2012 Aug; 80(2):485.e1-5. PubMed ID: 22503760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours.
    Cheng L; Zhang S; Wang M; Davidson DD; Morton MJ; Huang J; Zheng S; Jones TD; Beck SD; Foster RS
    J Pathol; 2007 Sep; 213(1):65-71. PubMed ID: 17634958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing.
    Bryce AH; Egan JB; Smadbeck JB; Johnson SH; Murphy SJ; Harris FR; Halling GC; Terra SBSP; Cheville J; Pagliaro L; Leibovich B; Costello BA; Vasmatzis G
    Sci Rep; 2019 Mar; 9(1):3586. PubMed ID: 30837548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
    Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
    Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.